Hydroxychloroquine is a drug which is being widely used to prevent or to treat malaria, which is caused by mosquito bites. This can also be used as a medication for treating specific auto-immune diseases which includes lupus, rheumatoid, arthritis etc. Hydroxychloroquine belongs to a class of medications which is termed as disease-modifying antirheumatic drugs or DMARDs.
The recent discussions among the doctors and politicians are sparring over whether the drug hydroxychloroquine can be used to treat against the novel coronavirus infection. Many scientists are of the opinion that the existing evidence is too thin in order to recommend the use of drug against coronavirus. Few of the small and the very preliminary studies have given across conflicting results which puts doctors in a situation of dilemma.
One study which was conducted in lab suggests that the drug has the ability in curbing the ability of coronavirus to enter the cell of a human body. Another research report concluded that it was discovered among 11 people that the drug did not improve how fast the patients could clear the virus or their symptoms. The drug has helped more than 100 people across 10 hospitals, says a report from China, but the report also mentioned that the patients showed varies degrees of illness and was being treated with various doses for varied lengths of time duration. It also suggests that they might have recovered without the drug also.
Another research which was also conducted in China says that, among 31 patients who were having cough, fever and pneumonia seemed to improve at a faster pace after giving them Hydroxychloroquine in comparison to another 31 patients who were not treated with the drug.
However, the risks that are associated with the Hydroxychloroquine consumption is that it can lead to heart rhythm problems, muscle or nerve damage and also causes severely low blood pressure levels in patients. Proper evidence of the usage of the drug has not yet been discovered by the experts and it still remains as a question mark whether the drug is benefitting the treatment against Covid-19 or not.